Case StudyDermatologyPhase IIa
Back to library
Phase IIa Moderate to Severe Hidradenitis Suppurativa Case Study
Top 5 pharma sought to randomise 192 patients with moderate to severe hidradenitis suppurativa at 60 sites across USA, Canada, and Australia; Innovative Trials delivered a multi-faceted, patient-centric recruitment strategy focused on site engagement.
Download the case studyClarity on your enrolment risk starts with one conversation.